← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 14, 2014Last known activity
Dec 15, 2022
Acquired by Chimerix → Jazz Pharmaceuticals on Jan 8, 2021
Timeline
2000s
- Mar 1, 2009
Oncoceutics, Inc.— Founded
2020s
- Jan 8, 2021
Chimerix— Acquired By
- Mar 5, 2025
Jazz Pharmaceuticals— Now
Drugs by trial phase (3 distinct, 17 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Astrocytoma
- Central Nervous System Neoplasms
- Choroid Plexus Neoplasms
- Colorectal Neoplasms
- Endometrial Neoplasms
- Ependymoma
- Glioblastoma
- Glioma
- Gliosarcoma
- Leukemia
- Lymphoma
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Medulloblastoma
- Meningioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms, Neuroepithelial
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Oligodendroglioma
- Pinealoma
- Preleukemia
- Rhabdoid Tumor
- Triple Negative Breast Neoplasms
Recent trials (17)
- NCT04617002Lead sponsorN/A—
- NCT05542407CollaboratorPhase 1Dec 15, 2022
- NCT04854044CollaboratorPhase 1May 1, 2021
- NCT04629209Lead sponsorPhase 2Dec 15, 2020
- NCT04541082Lead sponsorPhase 1Oct 26, 2020
- NCT03791398CollaboratorPhase 1/Phase 2Jun 30, 2019
- NCT03485729Lead sponsorPhase 2Mar 21, 2018
- NCT03416530Lead sponsorPhase 1Jan 29, 2018
- NCT03295396Lead sponsorPhase 2Oct 31, 2017
- NCT03099499CollaboratorPhase 2Jun 30, 2017
- NCT03134131Lead sponsorN/AApr 20, 2017
- NCT02863991Lead sponsorPhase 1/Phase 2Jan 1, 2016
- NCT02525692Lead sponsorPhase 2Jan 1, 2016
- NCT02420795CollaboratorPhase 1/Phase 2Nov 3, 2015
- NCT02392572CollaboratorPhase 1/Phase 2Nov 1, 2015
Details
- Founded
- Philadelphia, PA, US Mar 1, 2009
- Last known activity
- Dec 15, 2022